Thrombophlebitis and Phlebothrombosis

Slide 1 · Thrombophlebitis and Phlebothrombosis

Venous thrombosis • mechanisms • morphology • clinical consequences

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning goals

Explain how stasis and hypercoagulability produce venous thrombosis.

Recognize the major anatomic locations and venous thrombus morphology.

Interpret the often-silent presentation and serious embolic sequelae.

Apply the pathology to immobilization, malignancy, and inherited thrombophilia.

Slide 3 · Two terms describe related venous pathology

Thrombophlebitis and phlebothrombosis are used interchangeably.

Both refer to venous thrombosis with an associated inflammatory component.

In clinical reasoning, the location and embolic potential matter more than terminology.

Slide 4 · Most venous thromboses involve the deep leg veins

Deep leg veins account for more than 90% of cases in Chapter 11.

Proximal deep veins include the popliteal, femoral, and iliac veins.

These vessels are important sources of pulmonary thromboemboli.

Lower-extremity veins

Iliac vein

Femoral vein

Popliteal vein

Deep venous path (schematic)

Simplified named major proximal veins; Not anatomical scale

Slide 5 · Superficial and deep venous disease differ clinically

Superficial saphenous thromboses commonly accompany varicose veins.

Deep vein thrombosis has a stronger association with pulmonary embolization.

Both can obstruct venous drainage, but the principal hazard differs.

Feature

Superficial thrombosis

Deep vein thrombosis

Common setting

Varicosities / saphenous veins

Deep leg venous system

Dominant problem

Local tenderness / congestion

Pulmonary embolic potential

Embolization

Uncommon

More frequent

Editable comparison table

Slide 6 · Venous thrombosis belongs to the Virchow triad

Endothelial injury or activation

Abnormal blood flow, particularly stasis

Hypercoagulability: Inherited or acquired

More than one component may operate in the same patient.

Stasis / abnormal flow

Endothelial injury

Hypercoagulability

VENOUS

THROMBOSIS

Virchow triad: Interacting factors, not exclusive causes

Slide 7 · Stasis favors thrombosis in low-flow veins

Sluggish venous blood permits local accumulation of activated coagulation factors.

Washout by incoming blood becomes less effective.

Flow disturbances can also promote endothelial activation and leukocyte adhesion.

Reduced venous flow

Poor factor washout

Local procoagulant activity

Venous thrombus

Original editable causal schematic

Slide 8 · Laminar flow normally separates cells from endothelium

Circulating cellular elements tend to remain in the central stream.

A peripheral plasma layer limits sustained cellular contact with endothelium.

Stasis and disturbed flow weaken the protective effects of normal circulation.

Peripheral plasma layer

Cell-rich central flow

Flow distribution schematic, not microscopy

Slide 9 · The skeletal-muscle pump limits leg venous stasis

Leg-muscle contractions assist venous return against gravity.

Immobilization reduces the muscle-pump contribution.

The resulting slow venous flow creates a permissive thrombotic environment.

Walking / muscle action

Enhanced venous return

Less stagnation

Original editable causal schematic

Slide 10 · Prolonged bed rest is a major risk context

Immobility is identified as the most common cause of lower-extremity DVT in Chapter 11.

Reduced leg movement causes venous stasis.

Bedridden patients may have very few local warning symptoms.

Bed rest

Reduced calf-muscle action

Venous stasis

DVT risk

Original editable causal schematic

Slide 11 · Long-distance sitting reproduces the stasis mechanism

Long airplane or automobile journeys can involve extended sitting.

The shared exposure is prolonged reduction in leg movement.

An inherited predisposition can combine with this acquired risk.

Underlying predisposition

Acquired triggering exposure

Combined thrombosis susceptibility

Multi-hit model; Relationships are qualitative

Slide 12 · Postoperative DVT has multiple mechanistic drivers

Postoperative immobility suppresses venous return.

Tissue injury can release procoagulant activity.

Vascular injury and alterations in fibrinolysis further shift the balance toward clotting.

Stasis / abnormal flow

Endothelial injury

Hypercoagulability

VENOUS

THROMBOSIS

Virchow triad: Interacting factors, not exclusive causes

Slide 13 · Congestive heart failure promotes venous stasis

Reduced effective forward flow impairs venous return.

Stagnant leg venous blood favors coagulation.

Heart failure adds thrombotic risk even without a local leg injury.

Cardiac failure

Impaired venous return

Stasis

DVT susceptibility

Original editable causal schematic

Slide 14 · Pregnancy combines flow and coagulation changes

The gravid uterus impedes venous return from the legs.

Late pregnancy and the postpartum period also involve systemic hypercoagulability.

These effects act together, rather than as isolated risk factors.

Underlying predisposition

Acquired triggering exposure

Combined thrombosis susceptibility

Multi-hit model; Relationships are qualitative

Slide 15 · Estrogenic states favor coagulation

Oral contraceptive use is an acquired venous-thrombosis risk factor.

Higher hepatic synthesis of clotting factors and reduced anticoagulant synthesis are implicated.

The finding illustrates a systemic mechanism without a focal venous lesion.

Coagulation drive

Natural anticoagulants

Venous thrombosis risk rises when balance shifts

Qualitative schematic only; Not a measured scale

Slide 16 · Obesity and advanced age modify DVT risk

Obesity is included among acquired clinical risk factors.

Older age increases DVT risk irrespective of the immediate trigger.

The source does not require a single specific mechanism for each association.

Slide 17 · Inherited thrombophilia changes baseline susceptibility

Primary hypercoagulability follows inherited coagulation-pathway abnormalities.

Common examples include factor V Leiden and prothrombin G20210A.

Rare causes include deficiencies of natural anticoagulants.

Factor V Leiden

Prothrombin G20210A

Antithrombin deficiency

Protein C / S deficiency

Original editable conceptual grouping

Slide 18 · Factor V Leiden impairs normal anticoagulant control

Mutated factor V resists cleavage and inactivation by activated protein C.

Activated factor V activity therefore persists longer.

The net effect is an increased propensity to venous thrombosis.

Factor V Leiden

Resistance to protein C

Reduced inactivation

Thrombophilia

Original editable causal schematic

Slide 19 · Prothrombin G20210A increases procoagulant substrate

The 3′-untranslated-region variant is associated with increased prothrombin.

Greater prothrombin availability favors clot formation.

It is a distinct inherited mechanism from factor V Leiden.

G20210A variant

Raised prothrombin

Increased clotting tendency

Original editable causal schematic

Slide 20 · Deficient endogenous inhibitors permit excess thrombin

Antithrombin deficiency reduces physiologic thrombin inhibition.

Protein C and protein S deficiencies weaken natural anticoagulant activity.

Affected patients can develop recurrent venous thromboembolism at younger ages.

Coagulation drive

Natural anticoagulants

Venous thrombosis risk rises when balance shifts

Qualitative schematic only; Not a measured scale

Slide 21 · Inherited and acquired risks can interact

A thrombophilic genotype does not guarantee a thrombotic event.

Prolonged immobilization can supply an additional provoking factor.

The combined-risk model explains events arising after a recognizable trigger.

Underlying predisposition

Acquired triggering exposure

Combined thrombosis susceptibility

Multi-hit model; Relationships are qualitative

Slide 22 · Systemic hypercoagulability is not only genetic

Malignancy, pregnancy, estrogen use, and acquired immune-mediated disorders can shift coagulation.

Local venous stasis may amplify systemic susceptibility.

Clinically, one event can reflect several causal contributors.

Malignancy

Pregnancy / estrogen

Antiphospholipid syndrome

Immobilization + stasis

Original editable conceptual grouping

Slide 23 · Malignancy produces a prothrombotic state

Cancer, particularly adenocarcinoma, may induce paraneoplastic hypercoagulability.

Tumor cells can release procoagulants into the circulation.

The result may be venous thrombi without an obvious local vessel lesion.

Tumor-derived factors

Hypercoagulability

Venous thrombosis

Original editable causal schematic

Slide 24 · Trousseau syndrome is migratory thrombophlebitis

A venous thrombus appears at one site, resolves, and a new thrombus develops elsewhere.

This classic migratory pattern may accompany an underlying carcinoma.

The term refers to recurrent, anatomically changing thrombotic events.

Site A: Thrombosis

Apparent resolution

Site B: New thrombosis

Original editable causal schematic

Slide 25 · Migration means recurrence, not one moving clot

In Trousseau syndrome, successive local venous thromboses arise at different sites.

By contrast, embolization means actual detachment and transport of a thrombus fragment.

These are mechanistically distinct clinical descriptions.

Feature

Migratory thrombophlebitis

Thromboembolism

Process

New thromboses at separate sites

Detached clot fragment travels

Underlying issue

Persistent systemic procoagulant drive

Mechanical clot dislodgement

Typical concern

Occult malignancy association

Remote vascular obstruction

Editable comparison table

Slide 26 · Antiphospholipid syndrome is another acquired cause

Antiphospholipid antibodies are associated with recurrent thrombosis.

Endothelial, platelet, complement, and fibrinolytic pathways may be involved.

Venous thrombosis can coexist with other systemic manifestations.

Slide 27 · Deep veins outside the leg can also thrombose

Periprostatic veins and female pelvic venous plexuses are recognized sites.

Upper-extremity veins can also contain venous thrombi.

Anatomic site alters the local consequences and potential route of embolization.

Periprostatic plexus

Pelvic / periuterine veins

Upper-extremity veins

Lower-extremity deep veins

Original editable conceptual grouping

Slide 28 · Dural venous sinus thrombosis has a distinct location

Large veins within the skull and dural sinuses can thrombose.

Infection or inflammation is a recognized predisposing setting.

This site differs anatomically from the common lower-extremity DVT.

Local infection / inflammation

Dural venous sinus

Venous thrombosis

Original editable causal schematic

Slide 29 · Portal vein thrombosis can accompany abdominal infection

Peritonitis, appendicitis, salpingitis, or pelvic abscess may precede portal thrombosis.

This illustrates venous thrombosis occurring in an inflammatory setting.

Portal thrombosis can also arise with systemic thrombophilic disorders.

Intra-abdominal infection

Inflammatory setting

Portal venous thrombosis

Original editable causal schematic

Slide 30 · Polycythemia vera adds an unusual venous risk

Portal thrombosis with thrombophilic states including polycythemia vera.

Abnormal hematologic states can alter blood rheology or platelet function.

Consider a systemic driver when thrombosis occurs at an atypical site.

Slide 31 · The venous thrombus often forms an occlusive cast

Venous thrombi are usually nearly or completely occlusive.

The thrombus may fill a long segment of the venous lumen.

Grossly it is firm and focally adherent to the vessel wall.

Red cell–rich occlusive cast

Venous wall

Slide 32 · Venous thrombi are red-cell rich

Low-flow venous clots trap many erythrocytes within a fibrin network.

They contain relatively fewer platelets than arterial thrombi.

Thus the terms red thrombus and stasis thrombus are used.

Erythrocytes enmeshed in fibrin

Schematic composition; Relative proportions not quantitative

Slide 33 · Site of attachment records thrombus formation in life

Antemortem thrombi are usually focally attached to the venous wall.

The wall attachment marks the site of initiation.

An unattached tail may present greater embolic potential.

Toward heart

Adherent base

Propagating portion

Schematic: Direction and attachment; Not an observed specimen

Slide 34 · Venous thrombi may propagate toward the heart

Venous thrombi tend to extend in the direction of blood flow.

This growth can produce a longer luminal thrombus.

The propagating portion may remain relatively weakly attached.

Toward heart

Adherent base

Propagating portion

Schematic: Direction and attachment; Not an observed specimen

Slide 35 · Poorly attached portions may fragment

Propagation increases the mass of the venous thrombus.

A weakly adherent distal portion can detach.

Once detached, it becomes a thromboembolus and follows venous flow.

Propagating thrombus

Friable segment

Fragment detaches

Embolus

Original editable causal schematic

Slide 36 · Lines of Zahn show laminated thrombus formation

Alternating pale platelet–fibrin layers and darker erythrocyte-rich layers may be seen.

These laminations indicate formation in flowing blood.

They can help distinguish antemortem thrombi from postmortem clots.

Pale platelet / fibrin

Dark red-cell layer

Schematic laminations — not a microscopy image

Slide 37 · Antemortem thrombus versus postmortem clot

Antemortem: Firm, attached to wall, and may show lamination.

Postmortem: Gelatinous, typically not wall-attached.

Postmortem sedimentation produces dependent dark-red and upper yellow portions.

Criterion

Antemortem venous thrombus

Postmortem clot

Consistency

Firm

Gelatinous

Wall relationship

Focal attachment

Usually unattached

Internal pattern

Possible lines of Zahn

Red dependent / yellow upper layers

Editable comparison table

Slide 38 · Arterial and venous thrombi differ in dominant drivers

Arterial thrombi typically begin at endothelial injury or turbulence.

Venous thrombi characteristically form at sites of stasis.

Arterial thrombi are generally more platelet-rich; Venous thrombi more erythrocyte-rich.

Dimension

Venous thrombosis

Arterial thrombosis

Predominant flow factor

Stasis

Turbulence / injury

Composition

More red cells

More platelets

Clinical concern

Venous congestion / pulmonary embolus

Downstream ischemia / infarction

Editable comparison table

Slide 39 · A thrombus can follow four main paths

Propagation: Ongoing addition of fibrin and platelets.

Embolization: Detachment and movement to another vascular bed.

Dissolution: Fibrinolysis of thrombotic material.

Organization and recanalization: Cellular ingrowth and channel formation.

Formed venous thrombus

Propagation

Embolization

Dissolution

Organization / recanalization

Four nonexclusive fates

Slide 40 · Propagation can deepen venous obstruction

New fibrin and platelets are incorporated into the existing thrombus.

Thrombus length and degree of luminal blockage may increase.

Extension may also enlarge the portion vulnerable to embolization.

Initial thrombus

Fibrin / platelet addition

Larger thrombus

Greater obstruction

Original editable causal schematic

Slide 41 · Fibrinolysis can remove a recent thrombus

Activation of plasmin-mediated fibrinolysis may shrink a recent thrombus.

Older thrombi contain more cross-linked fibrin and resist lysis.

This difference explains why thrombus age influences reversibility.

Recent clot

Fibrinolytic activity

Clot shrinks / dissolves

Original editable causal schematic

Slide 42 · Organization converts thrombus to vascular tissue

Endothelial cells, smooth-muscle cells, and fibroblasts grow into the clot.

The original thrombus becomes progressively incorporated into the wall.

This is a reparative tissue response, not simply blood-clot persistence.

Organizing thrombus

Cellular ingrowth

Connective-tissue remodeling

Original editable causal schematic

Slide 43 · Recanalization can partially restore blood flow

Small vascular channels form within an organized thrombus.

These channels may reestablish continuity of the original lumen.

Restoration is variable, and residual fibrotic narrowing may persist.

New luminal channels

Schematic recanalization; Restored flow may be incomplete

Slide 44 · Venous blockage produces pressure-related effects

Outflow obstruction increases venous congestion distal to the clot.

Higher hydrostatic pressure promotes tissue edema.

Pain and swelling may occur, depending on the site and collateral drainage.

Venous occlusion

Congestion

Tissue edema

Local symptoms

Original editable causal schematic

Slide 45 · Collateral veins can conceal DVT symptoms

Alternate venous channels may open as the principal vein becomes blocked.

Collateral drainage reduces overt congestion and edema.

The absence of dramatic local findings therefore does not imply absence of thrombus.

Occluded segment

Collateral route

Original schematic — collateral flow may mask symptoms

Slide 46 · DVT can be clinically silent

Leg thrombi often produce few reliable local signs or symptoms.

Chapter 4 describes approximately half of DVTs as asymptomatic.

Pulmonary embolism may be the first recognized manifestation.

Slide 47 · Local findings are suggestive, not dependable

Potential findings include venous dilation, edema, cyanosis, warmth, erythema, and pain.

Any of these findings may be absent in a patient with DVT.

Clinical inspection alone cannot establish or exclude a thrombus.

Edema / venous dilation

Pain / tenderness

Warmth / erythema

Cyanosis

Original editable conceptual grouping

Slide 48 · Homan sign cannot exclude DVT

Pain with forced dorsiflexion has historically been called Homan sign.

Calf compression or pressure over veins can also provoke discomfort.

Absence of these findings does not exclude DVT; They are unreliable clinical signs.

Slide 49 · Superficial venous thrombosis has a different hazard profile

Thrombosed superficial saphenous veins may be painful and tender.

Local congestion and edema can impair superficial tissue drainage.

Embolization from these veins is much less common than from deep veins.

Presentation

Superficial veins

Deep veins

Local symptoms

Often prominent

May be absent

Superficial skin change

Congestion / ulcer risk

Not the defining feature

Pulmonary embolization

Rare

Major complication

Editable comparison table

Slide 50 · Chronic superficial venous congestion harms skin

Impaired venous outflow can cause sustained congestion and edema.

Stasis dermatitis and skin ulceration may complicate associated varicosities.

Poor healing and secondary infection compound tissue injury.

Superficial venous disease

Chronic congestion

Skin injury

Ulcer / infection

Original editable causal schematic

Slide 51 · DVT causes pulmonary embolism by clot detachment

A fragment of deep venous thrombus separates from its wall attachment.

It travels through progressively larger veins and the right heart.

It lodges in a pulmonary arterial vessel too small for onward passage.

Leg DVT

Large veins

Right heart

Pulmonary artery

Original editable causal schematic

Slide 52 · Pulmonary embolus location depends on fragment size

A large embolus may block the main pulmonary artery or straddle its bifurcation.

Smaller fragments lodge in branching pulmonary arterial vessels.

Several fragments can present simultaneously or sequentially.

Main pulmonary artery

Embolus at bifurcation

Schematic location only; Not a radiologic image

Slide 53 · Pulmonary embolism may reveal a previously silent DVT

An embolic event can be the first clinical evidence of thrombophlebitis.

The affected leg may have lacked recognizable symptoms.

This disconnect explains the importance of the embolic complication.

Silent DVT

Clot detaches

Pulmonary embolus

First presentation

Original editable causal schematic

Slide 54 · Pulmonary embolic burden determines the outcome

Smaller emboli may produce no clinical manifestations.

Major pulmonary vascular obstruction can induce acute right-heart failure or cardiovascular collapse.

The outcome varies with embolus size, number, and the affected vascular bed.

Small emboli

May remain silent

Major obstruction

Acute RV strain

Repeated emboli

Chronic pulmonary HTN

Qualitative consequences; Not a severity scoring system

Slide 55 · Pulmonary hemorrhage and infarction are not equivalent

The lung has both pulmonary and bronchial arterial supplies.

Bronchial flow may preserve viability despite pulmonary arterial blockage.

Infarction becomes more likely when bronchial perfusion is compromised.

Pulmonary artery

Bronchial arterial supply

Lung parenchyma

Possible obstruction

Potential collateral perfusion

Conceptual dual supply — infarction is context-dependent

Slide 56 · Small-vessel emboli may cause pulmonary infarction

Occlusion of smaller end-arteriolar branches may produce hemorrhage or infarction.

Pulmonary infarcts are commonly hemorrhagic because of dual blood supply and tissue structure.

The vascular site and remaining perfusion determine tissue outcome.

Peripheral embolus

Regional ischemia

Hemorrhage ± infarction

Original editable causal schematic

Slide 57 · Recurrent emboli can produce pulmonary hypertension

Repeated pulmonary embolization can chronically obstruct pulmonary vessels.

Elevated resistance to pulmonary flow develops.

Pulmonary hypertension may ultimately strain or fail the right ventricle.

Recurrent emboli

Pulmonary vascular obstruction

Pulmonary hypertension

Right-heart strain

Original editable causal schematic

Slide 58 · Case: Immobilization and unilateral leg symptoms

A hospitalized patient has prolonged bed rest and new asymmetric leg swelling.

Identify the dominant element of Virchow triad: Venous stasis.

Explain why the absence of calf pain would not exclude the suspected thrombus.

Bed rest

Reduced venous flow

DVT suspected

Which Virchow factor dominates?

Hypothetical teaching vignette — no actual patient or specimen

Slide 59 · Case: Recurrent thrombosis at changing sites

A patient develops superficial venous thromboses at anatomically separate sites over time.

The pattern suggests migratory thrombophlebitis.

Link the clinical pattern to a persistent systemic procoagulant state, classically malignancy.

Thrombosis: Site A

Resolves

New thrombosis: Site B

Why do anatomically separate events recur?

Hypothetical teaching vignette — no actual patient or specimen

Slide 60 · Case: Sudden pulmonary event without leg findings

A patient develops sudden cardiopulmonary compromise but had no obvious leg signs.

A deep venous thrombus may have been clinically silent.

A detached fragment may have obstructed the pulmonary arterial circulation.

Silent leg DVT

Clot detaches

Pulmonary embolus

Why could leg signs have been absent?

Hypothetical teaching vignette — no actual patient or specimen

Slide 61 · Case: Firm venous cast at autopsy

A firm red luminal cast is focally adherent to the venous wall.

Alternating pale and dark layers are visible in the clot.

This combination supports an antemortem venous thrombus rather than a postmortem clot.

Firm wall attachment

Laminated thrombus

Antemortem formation

Which findings support antemortem formation?

Hypothetical teaching vignette — no actual patient or specimen

Slide 62 · Integrated clinicopathologic model

Predisposition: Stasis and/or hypercoagulability, sometimes with endothelial dysfunction.

Lesion: An adherent, erythrocyte-rich, often occlusive venous thrombus.

Consequences: Local congestion, silent DVT, embolization, or organization.

Critical danger: Pulmonary embolism and possible chronic pulmonary hypertension.

Stasis / hypercoagulability

Venous thrombus

Occlusion or embolization

Local injury / pulmonary effects

Original editable causal schematic

Slide 63 · References and source limits

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. 2026. Chapter 11: Blood Vessels, pp. 471–472.

Same textbook, Chapter 4: Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 109–115.

Teaching material drawn from the supplied topic Markdown and robbins.md; original chapter PDF was not supplied.

Schematic diagrams are editable conceptual illustrations; no patient specimens are represented.